• Citer

A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.

par ten Bokkel Huinink, Wim;Prove, A M;Piccart-Gebhart, Martine ;Steward, W;Tursz, T;Wanders, Jantien;Franklin, H;Clavel, Michel;Verweij, Jaap;Alakl, M
Référence Annals of oncology, 5, 6, page (527-532)
Publication Publié, 1994-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
Auteur:	ten Bokkel Huinink, Wim; Prove, A M; Piccart-Gebhart, Martine; Steward, W; Tursz, T; Wanders, Jantien; Franklin, H; Clavel, Michel; Verweij, Jaap; Alakl, M
Informations sur la publication:	Annals of oncology, 5, 6, page (527-532)
Statut de publication:	Publié, 1994-07
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Breast cancer
	Docetaxel
MeSH keywords:	Adult
	Aged
	Antineoplastic Agents, Phytogenic -- administration & dosage
	Antineoplastic Agents, Phytogenic -- adverse effects
	Antineoplastic Agents, Phytogenic -- therapeutic use
	Breast Neoplasms -- drug therapy
	Drug Administration Schedule
	Drug Eruptions -- etiology
	Europe
	Female
	Humans
	Middle Aged
	Nervous System Diseases -- chemically induced
	Neutropenia -- chemically induced
	Paclitaxel -- administration & dosage
	Paclitaxel -- adverse effects
	Paclitaxel -- analogs & derivatives
	Paclitaxel -- therapeutic use
	Remission Induction
	Taxoids
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:scp/0028260937
	info:pmid/7918124